Our Business Philosophy
We believe in providing an equal opportunity environment to all our internal stakeholders where they have an equal stake in the well being of the organization and the community at large.
We believe that every associate of ours should have an equal say as to how we can grow our business by involving all the internal and external stakeholders in a manner that benefits our customers, consumers and the distribution system.
We believe profits are the ownership of not only the promoters but also the internal as well as the external stakeholders.
Our Mission
Our mission is to revolutionize metabolic care by delivering affordable and uniquely effective solutions,empowering individuals to manage their health while making advanced healthcare accessible to all.
Our Vision
Our vision is to lead the transformation of global metaboliccare by setting new benchmarks with affordable, unique,and high-quality solutions, creating a healthier world where everyone can achieve optimal metabolic health.
Parveen Nagpal
Inmed food Lifesciences has been founded by Parveen Nagpal, who has 30 years of experience in pharmaceutical sales and marketing with expertise in sales and marketing and worked as business unit head for some distinguished Indian MNC’s With the rich experience he intends to play a pivotal role in exploring and developing the medical food business in India.
His major aim is to bring original global brands and products in India and help bridge the gap between demand and supply of medical food products in the Indian market.
The reason for him to foray in this domain is the fact that in a fast moving life of today people often ignore their health and medical foods can play a big role in the same.
GP Singh
GP Singh, A global pharma CEO with 25+ years experience of successfully establishing and operating complex businesses in multiple geographies.
Before co-founding SHINKEI he has managed multiple types of pharmaceutical businesses across various geographies during his tenure in leadership role in various organizations in USA.
GP has particularly extensive expertise in establishing world-class commercial, manufacturing and development organizations and lead them on growth path through inorganic and organic growth strategies.
Suresh Borsadia
Suresh Borsadia is a senior-level executive with more than 25 years experience in pharmaceutical/drug delivery industry.
He has a demonstrated track record of value creation and successful deal closings, supplemented with a background and experience in R&D.
Prior to co-founding SHINKEI Therapeutics, he set-up Sun Pharma’s thin film technology capabilities, including commercial manufacturing.
He co-founded Abeille after working for Lavipharm, TheraTec Inc (Now Teva) and Bertek Inc ( Now Mylan) where he played a key role in R&D, in-licensing and out-licensing activities.
